InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Gilliam Joseph E, Chief Operating Officer. Director active across 1 companies, notably GLAUKOS Corp. Aggregated, 13 filings have been recorded. The latest transaction was filed on 21 January 2026 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
US$211,8214,502 shares@ US$47.05030.0033% mcap22.5% of flow
Common Stock
SEC:0001705850-26-000002·
€211,8214,502 shares@ €47.05030.0033% mcap8.9% of flow
Common Stock
SEC:0001705850-26-000002:0·
027,184 shares0
Common Stock
SEC:0001104659-22-073582:0·
€37,645672 shares@ €56.01940.0006% mcap1.6% of flow
Common Stock
SEC:0001104659-22-048497:0·
€73,5571,340 shares@ €54.89350.0011% mcap3.1% of flow
Common Stock
SEC:0001104659-22-042965:0·
03,886 shares0
Common Stock
SEC:0001104659-22-038982:0·
€28,615646 shares@ €44.29610.0004% mcap1.2% of flow
Common Stock
SEC:0001104659-22-035770:0·
€6,664159 shares@ €41.91450.0001% mcap0.7% of flow
Common Stock
SEC:0001104659-22-002372·
€6,664159 shares@ €41.91450.0001% mcap0.3% of flow
Common Stock
SEC:0001104659-22-002372:0·
€722,26110,549 shares@ €68.46720.011% mcap76.8% of flow
Common Stock
SEC:0001104659-21-063275·
€722,26110,549 shares@ €68.46720.011% mcap30.5% of flow
Common Stock
SEC:0001104659-21-063275:0·
10,000 shares
Common Stock
SEC:0001104659-21-061899·
€345,65210,000 shares@ €34.56520.0053% mcap14.6% of flow
Common Stock
SEC:0001104659-21-061899:0·
13 of 13 declarations
About Gilliam Joseph E
Joseph E. Gilliam is the President and Chief Operating Officer of GLAUKOS Corp. He oversees the company's operations and is responsible for growth strategy. His expertise in the medical sector is essential for guiding Glaukos towards innovation and expansion.
